Good day letter for Clasado, as FDA has no objections over Bimuno prebiotic’s GRAS status for formula
![Good day letter for Clasado, as FDA has no objections over Bimuno prebiotic’s GRAS status for formula](/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_small/publications/food-beverage-nutrition/nutraingredients-usa.com/article/2014/06/17/good-day-letter-for-clasado-as-fda-has-no-objections-over-bimuno-prebiotic-s-gras-status-for-formula/1848127-2-eng-GB/Good-day-letter-for-Clasado-as-FDA-has-no-objections-over-Bimuno-prebiotic-s-GRAS-status-for-formula.jpg)
Bimuno is a trans-galactooligosaccharide (GOS) second generation prebiotic, and had already recently received GRAS certification (GRN 000484), through scientific procedures, for use as an ingredient in a variety of food and beverage categories at levels ranging from 0.8 to 3.0 grams per serving (g/serving).
The ingredient has now also received GRAS certification (GRN 000495) for use as an ingredient in term infant formula and follow-on formula at up to 7.2 grams per liter (g/L) of reconstituted or ready-to-consume product.
“This recent GRAS approval for Clasado’s Bimuno is an important support to our commercial activity alongside our extensive program of scientific trials. Both of these continue to re-enforce and certify the various health benefits of Bimuno,” said Graham Waters, CEO, Clasado Inc.
Please click on the links below to read more about the science behind the ingredient:
From February 2013: ‘Second generation’ prebiotic shows potential against metabolic syndrome
From May 2008: Second-generation prebiotics get clinical trial support